Follow

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Account
Techi.com Techi.com

Apple wants to revolutionize medical research with ResearchKit

Senior Vice President of Operations at Apple Jeff Williams announced ResearchKit at the company’s big Spring Forward event today. ResearchKit is, as described by Williams, is a software framework that Apple wants to use to collect data from medical studies by turning the hundreds of millions of iPhones out there into tools for research and self-diagnosis that could overcome the many barriers that hinder medical research. 

Today at Apple’s press event in Cupertino, Senior Vice President of Operations Jeff Williams announced ResearchKit, a software framework aimed at helping to collect data for medical studies. The idea, said Williams, is to turn the more than 700 million iPhones sold worldwide into “powerful […] tools” for self-diagnosis and research. By overcoming the infrastructural barriers faced by medical professionals, namely subjective and infrequent sources of data, Apple hopes ResearchKit will help supply researchers with a much larger, more accurate pool from which to draw from for clinical trials. Apple has partnered with a number of hospitals and institutions ahead of ResearchKit’s official release next month, but Williams highlighted a few during the presentation. The University of Rochester, Xuanwu Hospital, and Capital Medical University worked in tandem to develop an app that can measure the progression of Parkinson’s disease. On the client side, users can test themselves by taking a timed tapping test or measuring their gait and balance, or keep track of their physical activity (which preliminary research suggests can slow the disease).

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use